Last reviewed · How we verify
Rubus occidentalis extract — Competitive Intelligence Brief
marketed
Botanical extract / Nutraceutical
Preventive health / Oncology (investigational)
Small molecule
Live · refreshed every 30 min
Target snapshot
Rubus occidentalis extract (Rubus occidentalis extract) — Korea University Anam Hospital. Rubus occidentalis (black raspberry) extract contains polyphenols and anthocyanins that exert antioxidant and anti-inflammatory effects to support cellular health.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Rubus occidentalis extract TARGET | Rubus occidentalis extract | Korea University Anam Hospital | marketed | Botanical extract / Nutraceutical |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Botanical extract / Nutraceutical class)
- Korea University Anam Hospital · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Rubus occidentalis extract CI watch — RSS
- Rubus occidentalis extract CI watch — Atom
- Rubus occidentalis extract CI watch — JSON
- Rubus occidentalis extract alone — RSS
- Whole Botanical extract / Nutraceutical class — RSS
Cite this brief
Drug Landscape (2026). Rubus occidentalis extract — Competitive Intelligence Brief. https://druglandscape.com/ci/rubus-occidentalis-extract. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing